Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Clinical Trial to Evaluate the Efficacy and Safety of PM8002 in Combination With Etoposide and Platinum in First-line Treatment of Extensive-Stage Small Cell Lung Cancer

NCT05844150 is registered in ClinicalTrials.gov with Biotheus Inc. as lead sponsor.

NCT NCT05844150
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05844150 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Clinical Trial to Evaluate the Efficacy and Safety of PM8002 in Combination With Etoposide and Platinum in First-line Treatment of Extensive-Stage Small Cell Lung Cancer
Lead sponsor
Biotheus Inc.
Phase
Phase 2
Overall status
Active, not recruiting
Start date
June 1, 2023
Completion date
December 31, 2025
Enrollment
50 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

sclc